ONCOBIOLOGICS INC - *W EXP 05/18/201 (ONSIZ)

CUSIP: 68235M121

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / *W EXP 05/18/201
Total 13F shares
2,439,678
Share change
-402,651
Total reported value
$1,273,000
Price per share
$0.50
Number of holders
10
Value change
-$268,450
Number of buys
1
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 68235M121?
CUSIP 68235M121 identifies ONSIZ - ONCOBIOLOGICS INC - *W EXP 05/18/201 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCOBIOLOGICS INC - *W EXP 05/18/201 (ONSIZ) as of Q1 2017

As of 31 Mar 2017, ONCOBIOLOGICS INC - *W EXP 05/18/201 (ONSIZ) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,439,678 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, PERCEPTIVE ADVISORS LLC, Cormorant Asset Management, LLC, venBio Select Advisor LLC, Marshall Wace North America L.P., PointState Capital LP, ACUTA CAPITAL PARTNERS, LLC, MILLENNIUM MANAGEMENT LLC, Monashee Investment Management LLC, and MORGAN STANLEY. This page lists 10 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.